Moreover, the post‐treatment tumor tissues of responders exhibited higher CCL5 expression than those of non‐responders in patients with melanoma (GSE91061), gastric cancer (PRJEB25780), and non‐small cell lung cancer (GSE135222) (Figure 8B). The gene discussed is CCL5; the disease is gastric cancer.